Dr. Johnstone et al. Reply to Dr. Elmrayed - 31/10/23
Doi : 10.1016/j.jaac.2023.07.994
Jeanette M. Johnstone, PhD a, b, ⁎ 
, L. Eugene Arnold, MD c, Amelia Villagomez, MD d, Lisa M. Robinette, MS c, Barbara L. Gracious, MD e, f, Hayleigh K. Ast, ND a, Alisha M. Bruton, ND, MS a, Irene E. Hatsu, PhD, RD c
, L. Eugene Arnold, MD c, Amelia Villagomez, MD d, Lisa M. Robinette, MS c, Barbara L. Gracious, MD e, f, Hayleigh K. Ast, ND a, Alisha M. Bruton, ND, MS a, Irene E. Hatsu, PhD, RD c a Oregon Health & Science University, Portland, Oregon
b National University of Natural Medicine, Helfgott Research Institute, Portland, Oregon
c The Ohio State University, Columbus, Ohio
d University of Arizona College of Medicine, Tucson, Arizona
e HCA Florida Orange Park Hospital, Orange Park, Florida
f Edward Via College of Osteopathic Medicine, Spartanburg, South Carolina
∗Correspondence to Jeanette Johnstone, PhD, Oregon Health & Science University, 3818 SW Sam Jackson Park Road, Portland, OR 97239Oregon Health & Science University3818 SW Sam Jackson Park RoadPortlandOR97219
Résumé |
We thank Dr. Elmrayed and colleagues1 for highlighting clinical cautions in using broad-spectrum micronutrients to treat attention-deficit/hyperactivity disorder (ADHD) in children, in particular manganese (Mn) levels. We appreciate the opportunity to provide additional information and rationale for the vitamin and mineral doses contained in the studied formula.
Le texte complet de cet article est disponible en PDF.| This work was funded by the Foundation for Excellence in Mental Health Care (Dr. Johnstone), the National Center for Complementary and Integrative Health (NCCIH) (K2390281846; 5R90AT00892403, Dr. Johnstone), and NCCIH T32AT002688 (Drs. Johnstone and Bruton), the Gratis Foundation (Dr. Johnstone), the National Center for Advancing Translational Sciences (UL1TR000128; UL1TR002369; 8UL1TR000090-05, OHSU and Ohio State), the Jeffrey Fellowship (Dr. Gracious), and the Calgary Foundation (Dr. Johnstone). |
|
| The research was performed with permission from the Institutional Review Board at OHSU #16870 and The Ohio State University (OSU) (#2017H0188), the Health Research Ethics Board at University of Calgary (#17-0325) for the University of Lethbridge, and FDA IND#127832 Health Canada (Control #207742). |
|
| Author Contributions Conceptualization: Johnstone, Arnold Data curation: Johnstone, Arnold Writing – original draft: Johnstone, Arnold, Villagomez, Robinette, Gracious, Ast, Hatsu Writing – review and editing: Johnstone, Arnold, Villagomez, Robinette, Gracious, Ast, Bruton, Hatsu |
|
| Disclosure: Please see the disclosure statement in the original article published May 2022. |
|
| All statements expressed in this column are those of the authors and do not reflect the opinions of the Journal of the American Academy of Child and Adolescent Psychiatry. See the Instructions for Authors for information about the preparation and submission of Letters to the Editor. |
© 2023
American Academy of Child and Adolescent Psychiatry. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 62 - N° 11
P. 1171-1175 - novembre 2023 Retour au numéro
Article précédent
- Dosages of Nutrient Supplements and Potential Long-Term Toxicity in Attention-Deficit/Hyperactivity Disorder Micronutrient Study
- Seham Elmrayed
- Joseph Biederman, MD (1947-2023)
- Atilla Ceranoglu, Robert Doyle, Stephen V. Faraone, Daniel Geller, Gagan Joshi, David Rubin, Thomas Spencer, Craig Surman, Mai Uchida, Timothy Wilens, Janet Wozniak
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?